Literature DB >> 16010677

Fragile X syndrome.

Alessandra Terracciano1, Pietro Chiurazzi, Giovanni Neri.   

Abstract

Fragile X syndrome, the most common genetic disorder associated with mental retardation is caused by an expansion of the unstable CGG repeat within the FMR1 gene. Although overgrowth is not the main hallmark of this condition, the fragile X syndrome is usually included in the differential diagnosis of children with mental retardation and excess growth. This review highlights the most recent advances in the field of fragile X research. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010677     DOI: 10.1002/ajmg.c.30062

Source DB:  PubMed          Journal:  Am J Med Genet C Semin Med Genet        ISSN: 1552-4868            Impact factor:   3.908


  25 in total

1.  Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization.

Authors:  Hansen Wang; Susan S Kim; Min Zhuo
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

Review 2.  Approach to the Diagnosis of Overgrowth Syndromes.

Authors:  Mohnish Suri
Journal:  Indian J Pediatr       Date:  2015-12-18       Impact factor: 1.967

3.  Depression in women with spontaneous 46, XX primary ovarian insufficiency.

Authors:  Peter J Schmidt; Jamie A Luff; Nazli A Haq; Vien H Vanderhoof; Deloris E Koziol; Karim A Calis; David R Rubinow; Lawrence M Nelson
Journal:  J Clin Endocrinol Metab       Date:  2010-11-03       Impact factor: 5.958

4.  A distinct DNA-methylation boundary in the 5'- upstream sequence of the FMR1 promoter binds nuclear proteins and is lost in fragile X syndrome.

Authors:  Anja Naumann; Norbert Hochstein; Stefanie Weber; Ellen Fanning; Walter Doerfler
Journal:  Am J Hum Genet       Date:  2009-10-22       Impact factor: 11.025

5.  Mapping of an origin of DNA replication in the promoter of fragile X gene FMR1.

Authors:  Bruna P Brylawski; Paul D Chastain; Stephanie M Cohen; Marila Cordeiro-Stone; David G Kaufman
Journal:  Exp Mol Pathol       Date:  2006-12-28       Impact factor: 3.362

Review 6.  Evaluation of current pharmacological treatment options in the management of Rett syndrome: from the present to future therapeutic alternatives.

Authors:  Christopher A Chapleau; Jane Lane; Lucas Pozzo-Miller; Alan K Percy
Journal:  Curr Clin Pharmacol       Date:  2013-11

Review 7.  Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.

Authors:  Emmanuel Peprah
Journal:  Ann Hum Genet       Date:  2011-12-21       Impact factor: 1.670

Review 8.  Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway.

Authors:  Anne Cheever; Stephanie Ceman
Journal:  RNA Biol       Date:  2009-04-17       Impact factor: 4.652

9.  Transcription factor FIGLA is mutated in patients with premature ovarian failure.

Authors:  Han Zhao; Zi-Jiang Chen; Yingying Qin; Yuhua Shi; Shan Wang; Youngsok Choi; Joe Leigh Simpson; Aleksandar Rajkovic
Journal:  Am J Hum Genet       Date:  2008-05-22       Impact factor: 11.025

10.  Whole genome microarray analysis of gene expression in subjects with fragile X syndrome.

Authors:  Douglas C Bittel; Nataliya Kibiryeva; Merlin G Butler
Journal:  Genet Med       Date:  2007-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.